Better Logo
Neuralink logo

Buy Neuralink Stock

Neuralink Stock Price - YTD Performance

$37.34
+5.65% (+$2.11)
Neuralink
JanMarMayAugOctDec $34.6 $36.3 $38.0 $39.7 $41.4

About Neuralink

Leading neuralink company transforming the industry through innovation.

Valuation
Loading...
Total Funding
$1.2B
Employees
Loading...
Founded
Loading...

Company Details

IndustryTechnology
HeadquartersSan Francisco, CA
CEON/A

Investment Data

Last FundingLoading...
Investors40+
Status
Private
TechnologyInnovation

Neuralink Financial Performance

Year20202021202220232024E2025E
Revenue$2.0B$5.4B$8.7B$15.0B$25.0B$40.0B
EBIT-$0.5B$0.8B$2.1B$4.5B$8.0B$14.0B

Revenue & EBIT Trend

Revenue
EBIT
Revenue Estimates
EBIT Estimates
$40.0B$30.0B$20.0B$10.0B$0.0B20202021202220232024E2025E
Data sourced from PitchBook, Crunchbase, Eulerpool, Reuters, Bloomberg, CB Insights, company investor relations, company management and Better Markets. Last updated: 8/3/2025

Market Intelligence

Live insights and analysis for Neuralink

Recent Articles

Latest market coverage and analysis

More Companies Like Neuralink

Explore other private equity opportunities in our marketplace

How to Buy Neuralink Stock: Complete Investment Guide

Everything you need to know about investing in Neuralink before IPO

How to invest in Neuralink before IPO?

Neuralink is a privately held company, but Better makes pre-IPO investing accessible to everyone—not just accredited investors. Unlike traditional platforms that require $250K+ minimums, Better allows you to buy Neuralink shares starting at just $1.

How it works: Create a free Better account, complete identity verification (takes 2 minutes), fund your account, and start trading Neuralink shares instantly with zero fees.

Can you buy Neuralink stock right now?

Yes! Neuralink shares are available on Better's secondary marketplace. Unlike other platforms that restrict access to accredited investors only, Better democratizes private equity investing for retail investors.

Better vs. traditional private equity: No accreditation requirements, no massive minimums, no long lock-up periods. Buy and sell Neuralink shares as easily as public stocks.

What is Neuralink's current stock price and valuation?

Neuralink's current trading price on Better is $37.34 per share, with a total valuation of Loading.... This pricing reflects real-time market demand and recent funding rounds.

Unlike private markets where pricing is opaque and outdated, Better provides live pricing with instant execution—no waiting weeks for trade settlement.

Can you sell Neuralink shares before it goes public?

Absolutely. Neuralink shares are fully liquid on Better's marketplace. You can sell your position instantly during market hours—no need to find individual buyers or wait for company approval.

Better advantage: Instant liquidity vs. traditional private equity that can take months to exit. No transfer restrictions, no company approval needed.

Is Neuralink publicly traded on NASDAQ or NYSE?

No, Neuralink remains privately held and is not available on public exchanges like NASDAQ or NYSE. However, Better provides the next best thing: a liquid secondary market for pre-IPO shares.

Better offers the convenience of public markets (instant trades, live pricing, zero fees) combined with access to exclusive private companies like Neuralink.

What are the fees for buying Neuralink stock?

Better charges zero trading fees for Neuralink transactions. No commissions, no platform fees, no hidden costs.

Compare: Traditional private equity platforms charge 2-8% fees. Better makes money through premium features, not by taking a cut of your investments.

What's the minimum investment for Neuralink shares?

Just $1. Better enables fractional ownership, so you don't need $100K+ like traditional private equity. Buy exactly the dollar amount you want to invest.

Perfect for portfolio diversification—own pieces of multiple private companies without massive capital requirements.

What happens to Neuralink shares when they IPO?

If Neuralink goes public, your Better shares typically convert to publicly traded shares at the IPO price, giving you immediate access to public market liquidity.

IPO advantage: Pre-IPO investors often see significant returns when private companies go public. Better positions you to capture this upside with professional-grade execution.

How does Better compare to other private equity platforms?

Better: Zero fees, $1 minimum, instant liquidity, retail-friendly

Traditional platforms: 2-8% fees, $250K+ minimums, long lock-ups, accredited-only

Better democratizes private equity investing with public market convenience and institutional-quality execution.

Is investing in Neuralink through Better safe and regulated?

Yes. Better operates under strict financial regulations with bank-level security. Your investments are protected by SIPC insurance, and all transactions are processed through regulated clearing systems.

Better combines the innovation of fintech with the security and compliance standards of traditional financial institutions.

USD
Shares66.952
Price per share$37.34
Total$2,500.00

Your Neuralink Position

Shares Owned28
Avg. Price$109.85
Market Value$3,150.00
Unrealized P&L
+$74.2
+2.4%

Order Book

Coming soon

Community Discussion

Coming soon

Sourced by AI • Updated recently

Current Price
$37.34

Don’t Miss Out on the Next Big Thing

Millions of investors already own unicorns before IPO. Start with $1 today.

Better Logo

Private equity for everyone.

LIVE Markets
12.752 Investors
$2.1B+ Deployed

Investing in private markets involves risk and may not be suitable for all investors. Investors risk losing their entire investment, including fees. You should carefully consider whether investing in private markets is appropriate for you based on your investment experience and financial resources. Better is designed for professional investors as defined under the applicable securities laws and regulations of their jurisdiction. Any investment decisions you make are solely your responsibility and at your own risk. Information is provided for informational purposes only on an "AS IS" basis. Past performance is not necessarily indicative of future results.

© 2025 Better Markets

Better - The Future of Private Equity